Wordt geladen...
Advances in the assessment of minimal residual disease in mantle cell lymphoma
The clinical impact of minimal residual disease detection at early time points or during follow-ups has been shown to accurately predict relapses among patients with lymphomas, mainly in follicular and diffuse large B cell lymphoma. The field of minimal residual disease testing in mantle cell lympho...
Bewaard in:
| Gepubliceerd in: | J Hematol Oncol |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7513535/ https://ncbi.nlm.nih.gov/pubmed/32972438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-020-00961-8 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|